Literature DB >> 32737153

Outcomes of Maternal-Newborn Dyads After Maternal SARS-CoV-2.

Sourabh Verma1,2, Chanda Bradshaw3,2, N S Freda Auyeung3, Rishi Lumba3, Jonathan S Farkas3,2, Nicole B Sweeney4, Elena V Wachtel3,2, Sean M Bailey3,2, Asif Noor4, Bgee Kunjumon3, Erin Cicalese3,2, Rahul Hate3, Jennifer L Lighter3,2, Samantha Alessi3, William E Schweizer5, Nazeeh Hanna4, Ashley S Roman6, Benard Dreyer3,2, Pradeep V Mally3,2.   

Abstract

BACKGROUND AND OBJECTIVES: Infection with a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic. There are limited data describing the impact of SARS-CoV-2 infection on pregnant mothers and their newborns. The objective of this study is to describe characteristics and outcomes of maternal-newborn dyads with confirmed maternal SARS-CoV-2.
METHODS: This was a multicenter, observational, descriptive cohort study with data collection from charts of maternal-newborn dyads who delivered at 4 major New York City metropolitan area hospitals between March 1 and May 10, 2020, with maternal SARS-CoV-2 infection.
RESULTS: There were a total of 149 mothers with SARS-CoV-2 infection and 149 newborns analyzed (3 sets of twins; 3 stillbirths). Forty percent of these mothers were asymptomatic. Approximately 15% of symptomatic mothers required some form of respiratory support, and 8% required intubation. Eighteen newborns (12%) were admitted to the ICU. Fifteen (10%) were born preterm, and 5 (3%) required mechanical ventilation. Symptomatic mothers had more premature deliveries (16% vs 3%, P = .02), and their newborns were more likely to require intensive care (19% vs 2%, P = .001) than asymptomatic mothers. One newborn tested positive for SARS-CoV-2, which was considered a case of horizontal postnatal transmission.
CONCLUSIONS: Although there was no distinct evidence of vertical transmission from mothers with SARS-CoV-2 to their newborns, we did observe perinatal morbidities among both mothers and newborns. Symptomatic mothers were more likely to experience premature delivery and their newborns to require intensive care.
Copyright © 2020 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2020        PMID: 32737153     DOI: 10.1542/peds.2020-005637

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  13 in total

1.  [Pediatrics up to date-Brief notes on research].

Authors:  R Kerbl
Journal:  Monatsschr Kinderheilkd       Date:  2020-11-20       Impact factor: 0.323

2.  Management and Early Outcomes of Neonates Born to Women with SARS-CoV-2 in 16 U.S. Hospitals.

Authors:  Jayme L Congdon; Laura R Kair; Valerie J Flaherman; Kelly E Wood; Mary Ann LoFrumento; Eberechi Nwaobasi-Iwuh; Carrie A Phillipi
Journal:  Am J Perinatol       Date:  2021-03-15       Impact factor: 1.862

3.  Adverse Perinatal Outcomes Predicted by Prenatal Maternal Stress Among U.S. Women at the COVID-19 Pandemic Onset.

Authors:  Heidi Preis; Brittain Mahaffey; Susmita Pati; Cassandra Heiselman; Marci Lobel
Journal:  Ann Behav Med       Date:  2021-03-20

4.  Outcomes of Late-Preterm and Term Infants Born to SARS-CoV-2-Positive Mothers.

Authors:  Youn Young Choi; SungHong Joo
Journal:  J Korean Med Sci       Date:  2022-05-09       Impact factor: 5.354

5.  Synthesis and systematic review of reported neonatal SARS-CoV-2 infections.

Authors:  Roberto Raschetti; Alexandre J Vivanti; Christelle Vauloup-Fellous; Barbara Loi; Alexandra Benachi; Daniele De Luca
Journal:  Nat Commun       Date:  2020-10-15       Impact factor: 14.919

6.  ASE Statement on Adapting Pediatric, Fetal, and Congenital Heart Disease Echocardiographic Services to the Evolving COVID-19 Pandemic.

Authors:  Carolyn A Altman; Mary T Donofrio; Bhawna Arya; Melissa Wasserman; Gregory J Ensing; Meryl S Cohen; Mark B Lewin; Madhav Swaminathan; Piers C A Barker
Journal:  J Am Soc Echocardiogr       Date:  2021-01-28       Impact factor: 5.251

Review 7.  SARS-CoV-2-Morphology, Transmission and Diagnosis during Pandemic, Review with Element of Meta-Analysis.

Authors:  Katarzyna Grudlewska-Buda; Natalia Wiktorczyk-Kapischke; Ewa Wałecka-Zacharska; Joanna Kwiecińska-Piróg; Katarzyna Buszko; Kamil Leis; Klaudia Juszczuk; Eugenia Gospodarek-Komkowska; Krzysztof Skowron
Journal:  J Clin Med       Date:  2021-05-03       Impact factor: 4.241

Review 8.  Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2.

Authors:  David A Schwartz; Denise Morotti
Journal:  Viruses       Date:  2020-11-15       Impact factor: 5.048

9.  Assessment of materno-foetal transmission of SARS-CoV-2: A prospective pilot study.

Authors:  D Arora; K S Rajmohan; Sudhir Dubey; Madhusudan Dey; Sanjay Singh; V G Nair; R P Tiwari; Shyamji Tiwari
Journal:  Med J Armed Forces India       Date:  2021-07-26

Review 10.  Is pregnancy an immunological contributor to severe or controlled COVID-19 disease?

Authors:  Nazeeh Hanna; Monica Hanna; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2020-08-20       Impact factor: 3.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.